Drug-labels.com

NTP-Mirtazapine Od Tablets: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Cancelled Pre Market
Strength:
15 mg, 30 mg, 45 mg
Active ingredient:

Patient Medication Information: uses, side effects, how to take - NTP-Mirtazapine Od Tablets

ABOUT THIS MEDICATION

What the medication is used for:

Mirtazapine belongs to a group of medications known as antidepressants. NTP-MIRTAZAPINE OD TABLETS have been prescribed to you to relieve your symptoms of depression. Treatment with theses types of medications is most safe and effective when you and your doctor have good communication about how you are feeling.

What it does:

Mirtazapine affects the chemical messengers in your brain that help control depression.

When it should not be used:

Do not use NTP-MIRTAZAPINE OD TABLETS, if you are allergic to it or any of the components (see “What the important nonmedicinal ingredients are”). Stop taking the drug and contact your doctor immediately if you experience an allergic reaction or any severe or unusual side effects.

What the medicinal ingredient is:

Mirtazapine

What the important nonmedicinal ingredients are: Aspartame, crospovidone, eudragit, magnesium stearate, mannitol, orange flavour, silicon dioxide and xylitol.

What dosage forms it comes in:

NTP-MIRTAZAPINE OD TABLETS are supplied as:

15 mg Tablets - white to off white, round, flat, beveled edge

tablet - one side of the tablet debossed with the number “93" and the other side debossed with the number “7303".

30 mg Tablets - white to off white, round, flat, beveled edge

tablet - one side of the tablet debossed with the number “93" and the other side debossed with

the number “7304".

45 mg Tablets - white to off white, round, flat, beveled edge

tablet - one side of the tablet debossed with the number “93" and the other side debossed with

the number “7305".

WARNINGS AND PRECAUTIONS

BEFORE you use NTP-MIRTAZAPINE OD TABLETS talk to your doctor or pharmacist about:

  • refrain from potentially hazardous tasks, such as driving a car or operating dangerous machines, until you are certain that this medication does not Affect your mental alertness or physical coordination;

  • all your medical conditions, including a history of seizures, liver or kidney disease, heart problems, diabetes, low blood pressure, glaucoma (increased intra-ocular pressure), high cholesterol and/or high triglycerides (fats in the blood), difficulties in urinating as a result of an enlarged prostate;
  • any medications (prescription or nonprescription) which you are taking, especially monoamine oxidase inhibitors (e.g., phenelzine sulphate, moclobemide, tranylcypromine sulphate, or selegeline), or any other antidepressants, drugs to treat anxiety;
  • any natural or herbal products you are taking (e.g., St.

    John’s Wort);

  • if you are pregnant or thinking of becoming pregnant, or if you are breast feeding;

  • your habits of alcohol consumption;

  • anticipated medical procedures;
  • any allergies to this drug or its ingredients or components of the container

INTERACTIONS WITH THIS MEDICATION

The presence of other medications may affect the use of NTP-MIRTAZAPINE OD TABLETS or NTP-MIRTAZAPINE OD TABLETS may affect the use of other medications. This may increase the cause of serious side effects. Examples are: Any medications (prescription or nonprescription) which you are taking, especially monoamine oxidase inhibitors (e.g., phenelzine sulphate, moclobemide, tranylcypromine sulphate, or selegeline), or any other antidepressants, including the herbal St. John’s Wort, drugs to treat anxiety (e.g. diazepam).

Avoid alcohol while taking mirtazapine.

Interactions with the laboratory tests have not been established.

PROPER USE OF THIS MEDICATION

Usual dose:

Mirtazapine is not indicated for use in children under the 18 years of age

  • It is very important that you take NTP-MIRTAZAPINE

    OD TABLETS exactly as your doctor has instructed.

Generally, most people receive between 15 mg and 45 mg per day.

  • Never increase or decrease the amount of NTP-

    MIRTAZAPINE OD TABLETS you are taking unless your doctor tells you to and do not stop taking this medication without consulting your doctor.

  • Some symptoms may begin to improve within about two weeks but significant improvement can take several weeks. Continue to follow the doctor’s instructions.
  • The tablets should be taken at the same time each day, preferably as a single evening dose (prior to sleep). Do not chew them.
  • Keep taking your tablets until the doctor tells you to stop. The doctor may tell you to take your medicine for several months. Continue to follow the doctor’s instructions.
  • Take out the tablet (make sure hands are dry) and place it on the tongue. The tablet will rapidly disintegrate and can be swallowed with water.

Overdose:

If you have taken a large number of pills all at once, contact your doctor or the nearest hospital emergency department or your nearest Poison Control Centre immediately, even though you may not feel sick. Show the doctor your pack of pills.

Missed Dose:

Do not take a double dose to make-up for a missed dose. If you forget to take the evening dose, wait and take your usual dose the next evening (before sleep).

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

You may experience some side effects such as increase in appetite, weight gain, drowsiness or sleepiness, swollen ankles or feet, occasional dizziness or faintness (especially when you get up quickly from a lying or sitting position) and headache. Some side effects are temporary. Consult your doctor if you experience these or other side effects, as the dose may have to be adjusted. During discontinuation of treatment, you may experience the following symptoms:

Dizziness, abnormal dreams, sensory disturbances (including paresthesias and electric shock sensations), agitation, anxiety, fatigue, confusion, headache, tremor, nausea, vomiting and sweating

You should contact your doctor immediately if you have the symptoms.

SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN AND WHAT TO DO ABOUT THEM

Symptom / effect Talk with your

doctor or pharmacist

Stop taking drug and

Only if severeIn all casescall your doctor or pharmacist
Commonanxiety, hostility, agitation, and self-harm or harm to others.T
Uncommon

shortage of white blood cells, fever, sore throat, mouth ulcers or any other signs of infection, seizures, attack of mania

(agitation, elation, and uncontrolled behaviour), yellowing of the skin or eyes

(jaundice), rash, abnormal sensation in the skin or restless legs.

T

This is not a complete list of side effects. For any unexpected effects while taking NTP-Mirtazapine OD Tablets, contact your doctor or pharmacist.

HOW TO STORE IT

Store at controlled room temperature, 15º - 30ºC. Protect from light and moisture. Use immediately upon opening individual tablet blister.

Keep in a safe place out of the reach of children.

Do not use NTP-MIRTAZAPINE OD TABLETS after the expiry date indicated on the package.

REPORTING SUSPECTED SIDE EFFECTS

To monitor drug safety, Health Canada collects information on serious and unexpected effects of drugs . If you suspect you have had a serious or unexpected reaction to this drug you may notify Health Canada by:

toll-free telephone: 866-234-2345

toll-free fax 866-678-6789

By email: cadrmp@hc-sc.gc.ca

By regular mail:

National AR Centre

Marketed Health Products Safety and Effectiveness Information Division

Marketed Health Products Directorate

Tunney’s Pasture, AL 0701C

Ottawa ON K1A 0K9

NOTE: Before contacting Health Canada, you should contact your physician or pharmacist.

MORE INFORMATION

This document plus the full product monograph, prepared for health professionals, can be obtained by contacting the sponsor, Teva Canada Ltd.,

at: 1-800-268-4127 ext. 5005

or druginfo@tevacanada.com

Teva Canada Limited

30 Novopharm Court

Toronto, Ontario

Canada, M1B 2K9

Last revised: September 26, 2013

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02370093

Revision date stated in the text: September 26, 2013

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for NTP-Mirtazapine Od Tablets

Rx or OTC
Prescription (Rx)?
DIN 02370093, 02370107, 02370115
Schedule(s) PRESCRIPTION
Active ingredient(s) Mirtazapine
Dosage form(s) Tablet (Orally-Disintegrating)
Route(s) of administration Oral
Drug class (WHO ATC)
  1. N Nervous system drugs
    1. N06 Psychoanaleptics
      1. N06A Antidepressants
        1. N06AX Other antidepressants
          1. N06AX11 Mirtazapine
Company TEVA CANADA LIMITED
Current status Cancelled Pre Market
Current status date August 6, 2015
Strengths and forms
DIN Strength Dosage form(s) Current status
02370093 15 MG Tablet (Orally-Disintegrating) Cancelled Pre Market August 6, 2015
02370107 30 MG Tablet (Orally-Disintegrating) Cancelled Pre Market August 6, 2015
02370115 45 MG Tablet (Orally-Disintegrating) Cancelled Pre Market August 6, 2015

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.